61360007: Polymyxin B sulfate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Polymyxin (substance)\Polymyxin B sulfate

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Polymyxin (substance)\Polymyxin B sulfate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Cyclic peptide (substance)\Polymyxin (substance)\Polymyxin B sulfate

\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Cyclic peptide (substance)\Polymyxin (substance)\Polymyxin B sulfate
\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Cyclic peptide (substance)\Polymyxin (substance)\Polymyxin B sulfate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Polymyxin B sulfate	Is a	Product containing polymyxin B (medicinal product)	false	Inferred relationship	Some
Polymyxin B sulfate	Is a	Polymyxin B (substance)	false	Inferred relationship	Some
Polymyxin B sulfate	Is a	Polymyxin (substance)	true	Inferred relationship	Some
Polymyxin B sulfate	Is a	allergène médicamenteux	false	Inferred relationship	Some
Polymyxin B sulfate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Polymyxin B (substance)	true	Inferred relationship	Some
Polymyxin B sulfate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Polymyxin B sulf [systemic]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Polymyxin B sulf [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Polymyxin B sulfate [skin]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Polymyxin b sulfate 100% powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Polymyxin B sulfate+trimethoprim eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Polymyxin B sulfate+bacitracin zinc eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Polymyxin B sulfate+trimethoprim eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Polymyxin B sulfate+bacitracin zinc 10,000u/500u ophthalmic ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unit/3.5mg/10000unit ophthalmic ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Bacitracin zinc + polymyxin b sulfate 500unt/10000unt ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unit ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/3.5mg/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Gramicidin + neomycin sulfate + polymyxin b sulfate 0.025mg/1.75mg/10000unt solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/1.6mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/3.5mg/10000 unit suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/7.5mg/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/7.5mg/1000unt solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Polymyxin b sulfate + trimethoprim sulfate 10000unt/1mg ophthalmic solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Polymyxin b sulfate + trimethoprim sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Product containing neomycin sulfate and polymyxin B sulfate and zinc bacitracin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
médicament contenant dexaméthasone et néomycine et polymyxine B	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Bacitracin zinc + polymyxin b sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Polymyxin B sulfate 500,000u powder for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate and zinc bacitracin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate	Inferred relationship	Some
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Polymyxin B sulfate	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
101950019	Polymyxin B sulfate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
498992017	Polymyxin B sulphate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
800413012	Polymyxin B sulfate (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
43161000188110	polymyxine B sulfate	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
834511000172117	sulfate de polymyxine B	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module